I agree, RVXoldtimer.  Zenith shareholders hold an RPS interest in RVX's success so it would be in their interest to not let RVX fail in commercializing apabetalone, so I don't see the conflict of interest in Zenith loaning to or investing in RVX.  Zenith chairman recently exclamated that the RVX Royalty Preferred Shares were worth an enormous amount to Zenith.

So there you have it, right from the horse's mouth.

Geez KBC, could you not save us all from the obvious banter, and just pay the Ask...  

No one here is hanging on your every insinuation for direction on 'buy or sell'.  

JMHO